Literature DB >> 11765347

Hyperthyroidism with concurrent thyroid cancer.

E Zanella1, F Rulli, M Sianesi, S Sciacchitano, D Danese, A Pontecorvi, A M Farinon.   

Abstract

The occurrence of thyroid malignancy is considered a rare event in hyperthyroid patients. With the aim of assessing the clinical relevance of this association, we have analyzed the incidence of thyroid cancer in hyperthyroid patients treated by surgery. The incidence of thyroid cancer was retrospectively evaluated in 202 hyperthyroid patients who underwent thyroidectomy during a twenty-year period. A thyroid cancer was diagnosed in 12 cases (5.9 per cent). Histologic examination revealed the presence of papillary carcinoma in 9 cases, follicular carcinoma in 1 case and Hürthle cell carcinoma in 2 cases. The association between thyroid cancer and hyperthyroidism was more frequent in toxic adenomas (17.8 per cent) than in toxic diffuse (5.3 per cent) or multinodular goiters (1.7 per cent). In 8 patients they presented as an occult carcinoma (maximum diameter below 1 cm), but unfavourable histologic features, such as local invasiveness and multifocality, were found in 5 of them. Follow-up data indicate that all 12 patients are currently alive and apparently free of disease. Hyperthyroid patients, particularly those affected by toxic adenomas, should be carefully evaluated to exclude the presence of concurrent malignancy. A special attention should be made moreover to the presence of "occult" lesions that, in our study was characterized in a higher proportion (62.5 per cent) of cases, by unfavourable histologic features.

Entities:  

Mesh:

Year:  2001        PMID: 11765347

Source DB:  PubMed          Journal:  Ann Ital Chir        ISSN: 0003-469X            Impact factor:   0.766


  2 in total

1.  Papillary thyroid carcinoma and inflammation.

Authors:  Laura Fugazzola; Carla Colombo; Michela Perrino; Marina Muzza
Journal:  Front Endocrinol (Lausanne)       Date:  2011-12-16       Impact factor: 5.555

2.  Incidental thyroid carcinoma in surgery-treated hyperthyroid patients with Graves' disease: a systematic review and meta-analysis of cohort studies.

Authors:  Qingyi Jia; Xiaodan Li; Ying Liu; Ling Li; Joey Sw Kwong; Kaiyun Ren; Yong Jiang; Xin Sun; Haoming Tian; Sheyu Li
Journal:  Cancer Manag Res       Date:  2018-05-21       Impact factor: 3.989

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.